Investment
Features
FeesSafety
Academy
More
Pluang+

DSV A/S announces recent share transactions by a company manager under EU regulations.

Market News
24 Jul 2026
Dsv A/S
View Source
Neutral
pluang ai news

DSV A/S has disclosed transactions involving its shares made by a company manager, complying with EU regulation 596/2014. This announcement ensures transparency about insider trading activities within the company. The notification includes contact details for investor relations for further inquiries. Such disclosures are important for maintaining investor confidence and regulatory compliance.

More News

Competitive intelligence tool market to reach $18.11B by 2035, driven by AI and cloud analytics growth.

Competitive intelligence tool market to reach $18.11B by 2035, driven by AI and cloud analytics growth.

The global competitive intelligence tool market, valued at $6.46 billion in 2025, is projected to grow to $18.11 billion by 2035 with an 11.08% CAGR. Growth is fueled by rising demand for real-time market intelligence, AI-powered analytics, cloud ado...

Market News
Bullish
34 minutes ago
Bekaert repurchases 50,000 shares worth €2.06M, holding 3.65% of total shares as of July 22, 2026.

Bekaert repurchases 50,000 shares worth €2.06M, holding 3.65% of total shares as of July 22, 2026.

Between July 16 and 22, 2026, Bekaert repurchased 50,000 of its own shares totaling approximately €2.06 million as part of its ongoing buyback program announced in February 2026. The company plans to cancel all repurchased shares to reduce share capi...

Company Fundamentals
Neutral
49 minutes ago
Bekaert repurchases 50,000 shares worth €2.06M and updates liquidity agreement activity.

Bekaert repurchases 50,000 shares worth €2.06M and updates liquidity agreement activity.

Bekaert continued its share buyback program from July 16 to 22, 2026, repurchasing 50,000 shares at an average price of €41.15, totaling about €2.06 million. The company aims to cancel all repurchased shares, reducing the total outstanding shares. Ad...

Company Fundamentals
Bullish
49 minutes ago
Sanofi halts global regulatory submission for amlitélimab in moderate to severe atopic dermatitis.

Sanofi halts global regulatory submission for amlitélimab in moderate to severe atopic dermatitis.

Sanofi has decided to stop the clinical development of amlitélimab, an antibody for moderate to severe atopic dermatitis, after strategic review showed insufficient efficacy and safety benefits. Despite some positive long-term results from the phase ...

Market News
Bearish
1 hour ago
BitMEX faces class action lawsuit for allegedly profiting from forced Bitcoin liquidations before its September shutdown.

BitMEX faces class action lawsuit for allegedly profiting from forced Bitcoin liquidations before its September shutdown.

BitMEX is being sued in a proposed class action in the U.S. accusing the crypto derivatives exchange of engineering forced liquidations to retain over 622 BTC before its planned shutdown in September. Plaintiffs claim BitMEX liquidated customer posit...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App